METIS THERAPEUTICS
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
METIS THERAPEUTICS
Industry:
Biopharma Biotechnology Genetics Health Care Machine Learning
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.metistx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
176.22 M USD
Similar Organizations
Rubix LS
Rubix LS primary goal is to eradicate rare diseases through transformative research and development, breakthroughs in engineering.
Rheos Medicines
A biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease.
Renova Therapeutics
Renova Therapeutics is an industry leader in the emerging field of gene therapy, pursuing the development of treatments.
Receptos
Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.
ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Nereid Therapeutics
Nereid Therapeutics is discovering new disease treatments by applying research and technologies in biomolecular condensates.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Nodexus
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
VistaPath Biosystems
VistaPath Biosystems develops a tissue grossing platform that automates the process of inspecting, inking, and measuring tissues.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Vascular Pharmaceuticals
Vascular Pharmaceuticals is a drug discovery company developing monoclonal antibody treatments for diabetic nephropathy.
Valisure
Valisure is a digital pharmacy to chemically validate medications for quality and consistency.
Mytide Therapeutics
Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.
Memo Therapeutics
Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.
Libero Thera
Libero Thera provides drug discovery research and development services.
LPATH
Lpat focuses on the discovery and development of monoclonal antibodies that target bioactive lipids.
LUCA Biologics
Live biotherapeutics targeting the vaginal microbiome for unmet medical needs in urogenital and reproductive health.
Ariel Precision Medicine
Ariel Precision Medicine medicine solutions for diagnosis, monitoring, and treatment of diseases and disorders.
Antera Therapeutics
Antera Therapeutics is creating therapies that will prevent allergy development in children.
Adendra Therapeutics
Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.
Artizan Biosciences
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.
AnTolRx
Our lead program addresses significant unmet needs in the field of Type 1 Diabetes
Anivive
Anivive is focuses on reshaping pet healthcare by bringing together experts in software development, veterinary & clinical research.
Apostle
Apostle Inc is a provider of innovative technologies and services for public health and life sciences.
ExcepGen
ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.
Eton Pharmaceuticals
Eton Pharmaceuticals develops proprietary formulations of approved molecules in ways that offer improvements for patients and physicians.
EGenesis
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
Epic Therapeutics
Epic Therapeutics, Inc. operates as a drug delivery company.
BioNex Solutions
BioNex Solutions develops advanced laboratory automation systems for applications in biopharmaceutical, biotech and academic research.
Bionaut Labs
Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.
The ODIN
The ODIN provides kits and tools that helps consumers make organisms at home.
Torigen Pharmaceuticals
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.
Tavotek Biotherapeutics
Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.
Juvena Therapeutics
Juvena Therapeutics is a biopharmaceutical platform which is discovering novel protein-based therapeutics.
Quartet Medicine
Quartet Medicine is discovering and developing novel treatments
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
SHINEKING BIOTECH
SHINEKING BIOTECH specializes in the research and development and production of bio polymers.
SanaRx Biotherapeutics
SanaRx Biotherapeutics is designed to improve detection, visualization and treatment of 3 rare diseases.
Switchback Systems
Switchback Systems is an early stage startup working to democratize DNA synthesis.
SparX Group
SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.
Deciduous Therapeutics
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
Dyve Biosciences
Dyve creates novel therapeutics using proprietary science that leverages the skin as a portal for systemic delivery.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Humane Genomics
Humane Genomics is a virus development platform that develops artificial viruses to cure diseases.
I Peace
I Peace, Inc. is a CDMO specializing in iPSC-derived cell products. We provide cGMP manufacturing service and personal iPSC banking service.
Idorsia
The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
ImmuneOnco Biopharma
ImmuneOnco is a tumor immunotherapy product developer engaged in the development and research of tumor immunotherapy products.
Gameto
Gameto is a biotechnology firm focused on female reproductive fertility biotech.
Gemini Therapeutics
Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.
Gaba Therapeutics
Gaba Therapeutics is a therapeutic company that develops anxiety medications.
Omega Therapeutics
Omega Therapeutics offers a proprietary epigenomic programming platform.
OneThree Biotech
OneThree Biotech redesigns drug discovery with biology-driven artificial intelligence.
Orreco
Orreco provides biomarker analysis for athletes, federations, and professional franchises.
Ovid Therapeutics
Ovid Therapeutic's purpose is to solve intractable medical problems.
Ona Therapeutics
Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.
Odyssey Therapeutics
Odyssey Therapeutics provides medicines to patients with inflammatory diseases and cancer.
3T Biosciences
3T Biosciences is an immunotherapy company headquartered in Menlo Park, California.
Coordination Pharmaceuticals
Coordination Pharmaceuticals is a drug development company that aims to address unmet medical needs and improve patient care.
Cerecor
Cerecor discovers, develops and commercializes neuroscience drugs.
Chamishi Therapeutics
Chamishi Therapeutics is a drug discovery and development company focused on neurodegenerative diseases and other related disorders.
Canopy Biosciences
Canopy Biosciences aims to accelerate the commercialization of life science reagent tools and services through in-licensing.
Clade Therapeutics
Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.
Cardiol Therapeutics
Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
CRISPR Therapeutics
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Cleave Therapeutics
Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.
Psy Therapeutics
Psy Therapeutics is discovering and developing novel medicines to improve the lives of people affected by central nervous system disorders.
Current Employees Featured
Founder
Investors List
5Y Capital
5Y Capital investment in Series B - METiS Therapeutics
Lightspeed China Partners
Lightspeed China Partners investment in Series B - METiS Therapeutics
Monolith Management
Monolith Management investment in Series B - METiS Therapeutics
FREES FUND
FREES FUND investment in Series B - METiS Therapeutics
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - METiS Therapeutics
PICC Capital Investment Management
PICC Capital Investment Management investment in Series B - METiS Therapeutics
China Life Private Equity Investment
China Life Private Equity Investment investment in Series B - METiS Therapeutics
Sequoia Capital China
Sequoia Capital China investment in Series B - METiS Therapeutics
Lightspeed China Partners
Lightspeed China Partners investment in Series A - METiS Therapeutics
Picc Group
Picc Group investment in Series A - METiS Therapeutics
Official Site Inspections
http://www.metistx.com Semrush global rank: 7.27 M Semrush visits lastest month: 548
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "METiS Therapeutics" on Search Engine
METiS Therapeutics | AI drug discovery
Jan 6, 2023 Our Mission. Build a world-class proprietary predictive AI platform to redefine drug discovery. Create a robust and targeted delivery system for small molecules, RNA and gene therapies. Provide clinical value to patients by exploring the uncharted territory of AI and the new biology. Partnering.See details»
METiS Therapeutics - Crunchbase Company Profile & Funding
Dec 7, 2021 Legal Name METiS Therapeutics Inc. Company Type For Profit. Contact Email [email protected]. METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.See details»
METiS Therapeutics | LinkedIn
METiS Therapeutics | 1,602 followers on LinkedIn. Redefining drug discovery and delivery with a data-driven platform to develop best-in-class treatments | The METiS platform (AiTEM) combines...See details»
METiS Therapeutics Launches With $86 Million Series A …
Dec 7, 2021 METiS Therapeutics is a biotechnology company that aims to drive best-in-class therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine...See details»
METiS Announces License Agreement with Evopoint Biosciences
Jan 6, 2023 CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- METiS Therapeutics (METiS), a Boston-area company integrating drug discovery and delivery with AI and machine learning, today announced they have entered...See details»
METiS Therapeutics - Funding, Financials, Valuation & Investors
Funding. METiS Therapeutics has raised a total of. $176.2M. in funding over 3 rounds. Their latest funding was raised on Apr 5, 2022 from a Series B round. METiS Therapeutics is funded by 11 investors. 5Y Capital and Lightspeed China Partners are the most recent investors. Unlock for free.See details»
Metis Therapeutics emerges with $86M for 2022 clinic entry, push …
Dec 7, 2021 Metis Therapeutics emerges with $86M for 2022 clinic entry, push into gene therapy. By Kyle LaHucik Dec 7, 2021 6:00am. Cell & Gene Therapy CRISPR Emerging Biopharma funding. The idea began...See details»
METiS Announces Pan-RAF Inhibitor License Agreement with …
Sep 13, 2022 CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--METiS Therapeutics, a Boston-area company integrating drug discovery and delivery with AI and machine learning, today announced they have entered a...See details»
METiS Announces Pan-RAF Inhibitor License Agreement with …
CAMBRIDGE, Mass., September 13, 2022 -- ( BUSINESS WIRE )--METiS Therapeutics, a Boston-area company integrating drug discovery and delivery with AI and machine learning, today announced they...See details»
Metis Therapeutics emerges with $86M for 2022 clinic entry, push …
Dec 13, 2021 Metis Therapeutics emerges with $86M for 2022 clinic entry, push into gene therapy - Biotech Today. Posted on December 13, 2021 By News Team. The idea began when Chris Lai, Ph.D., met with MIT researchers at a …See details»
METiS Therapeutics Launches With $86 Million Series A …
Dec 7, 2021 METiS Therapeutics debuts today with $86 million Series A financing to harness artificial intelligence (AI) and machine learning to redefine drug discovery andSee details»
METiS Announces License Agreement with Evopoint Biosciences
Jan 6, 2023 METiS is a biotechnology company that aims to drive best-in-class therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation. To learn more, please visit metistx.com. About Evopoint.See details»
METiS Inks Exclusive Licensing Agreement With Evopoint …
Jan 6, 2023 Home. Disease Areas. Precision Oncology. METiS Inks Exclusive Licensing Agreement With Evopoint Biosciences for SOS1 Inhibitor. Jan 06, 2023 | staff reporter. Save for later. NEW YORK – METiS Therapeutics on Friday said it has signed an exclusive licensing agreement to develop and commercialize Evopoint Biosciences' SOS1 inhibitor …See details»
Series B - METiS Therapeutics - 2022-04-05 - Crunchbase
Apr 5, 2022 METiS Therapeutics. Announced Date Apr 5, 2022. Funding Type Series B. Funding Stage Early Stage Venture. Money Raised. $75M. Lead Investors. PICC Capital Investment Management PICC Capital Investment Management is a privately owned investment manager. Investors. Number of Investors 8. Recent News. News • Apr 6, 2022.See details»
Director, R&D Project Management | METiS Therapeutics
Provide effective and efficient project management for drug discovery and development R&D projects. Work with the team to develop project strategy, plan, timeline and budget. Perform risks analyses, develop mitigation plans, contingencies, new opportunities, and identify critical path activities.See details»
METiS Therapeutics | CipherBio
Get access to curated funding data. Explore METiS Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
METiS Therapeutics Launches With $86 Million Series A …
Dec 7, 2021 METiS Therapeutics is a biotechnology company that aims to drive best-in-class therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation. To learn more, visit www.metistx.com/ . Contacts. Company/Partner: METiS Therapeutics. (857) 225 6890. …See details»
Sr / Principal Scientist, Medicinal Chem | METiS Therapeutics
Cambridge, MA · Full-Time. Reports To: Director of Medicinal Chemistry. Company Overview. METiS Therapeutics Inc is a biotechnology company with a unique technology platform that has the potential to drive best-in class drug assets in a wide range of therapeutic areas.See details»
The Pipeline – METIS
METIS’ Pipeline. METIS platform allow the Company to unlock complex targets and develop antibody-based drugs designed for greater efficacy and longer duration. hOA-DN30. MET DecAb# DO-24. DN30 + radiotherapy. Expanding the target. The MET family of oncogenes. MET is not the only responsible gene for the control of invasive growth.See details»
Senior Manager | METiS Therapeutics
Cambridge, MA · Full-time. Reports To: VP, Business Development. Company Overview. METis Pharmaceuticals Inc is a biotechnology company with a unique technology platform that has the potential to drive best-in-class drug assets in a …See details»